The use of intravenous immunoglobulin therapy in a tertiary pediatric hospital

Ali Güngör; Neşe Yaralı

doi:10.15537/smj.2020.2.24877

Article Information

vol. 41 no. 2 163-167

DOI

https://doi.org/10.15537/smj.2020.2.24877

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Received November 4, 2019
Accepted December 25, 2019
Published online February 1, 2020.

Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

Ali Güngör, MD ⇑ and
Neşe Yaralı, MD

From the Department of Pediatrics (Gungor) and form the Department of Pediatric Hematology and Oncology (Yarali), Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Anakara, Turkey

Address correspondence and reprint request to: Dr. Ali Güngör, Department of Pediatrics, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey. E-mail: gungorali19{at}gmail.com ORCID ID: https://orcid.org/0000-0003-4139-3480

View Full Text